MARKER THERAPEUTICS INC's ticker is MRKR and the CUSIP is 57055L107. A total of 52 filers reported holding MARKER THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $2,731 | -45.4% | 10,273 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $5,000 | -50.0% | 10,273 | 0.0% | 0.00% | -50.0% |
Q4 2021 | $10,000 | -41.2% | 10,273 | 0.0% | 0.00% | -33.3% |
Q3 2021 | $17,000 | -41.4% | 10,273 | 0.0% | 0.00% | -50.0% |
Q2 2021 | $29,000 | +26.1% | 10,273 | 0.0% | 0.01% | +20.0% |
Q1 2021 | $23,000 | +53.3% | 10,273 | 0.0% | 0.01% | +66.7% |
Q4 2020 | $15,000 | 0.0% | 10,273 | 0.0% | 0.00% | -25.0% |
Q3 2020 | $15,000 | -28.6% | 10,273 | 0.0% | 0.00% | -33.3% |
Q2 2020 | $21,000 | +5.0% | 10,273 | 0.0% | 0.01% | -14.3% |
Q1 2020 | $20,000 | -33.3% | 10,273 | 0.0% | 0.01% | -22.2% |
Q4 2019 | $30,000 | -42.3% | 10,273 | 0.0% | 0.01% | -43.8% |
Q3 2019 | $52,000 | -35.8% | 10,273 | 0.0% | 0.02% | -36.0% |
Q2 2019 | $81,000 | +19.1% | 10,273 | 0.0% | 0.02% | +13.6% |
Q1 2019 | $68,000 | +19.3% | 10,273 | 0.0% | 0.02% | 0.0% |
Q4 2018 | $57,000 | – | 10,273 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 3,142,857 | $1,163,000 | 0.77% |
NEA Management Company, LLC | 10,714,285 | $3,951,000 | 0.20% |
ACT CAPITAL MANAGEMENT, LLC | 354,400 | $131,000 | 0.18% |
Long Focus Capital Management, LLC | 1,461,000 | $539,000 | 0.05% |
AR ASSET MANAGEMENT INC | 279,000 | $103,000 | 0.03% |
MATRIX ASSET ADVISORS INC/NY | 400,000 | $148,000 | 0.02% |
Mandatum Life Insurance Co Ltd | 99,000 | $37,000 | 0.01% |
WealthTrust Axiom LLC | 22,700 | $8,000 | 0.00% |
Riggs Asset Managment Co. Inc. | 18,500 | $7,000 | 0.00% |
NEVILLE RODIE & SHAW INC | 60,202 | $22,000 | 0.00% |